IMU

5.08%

6.2¢ imugene limited

Ann: Imugene Presentation to JPMorgan Healthcare Conference, page-62

First 62 Last

Share
Profile

Follow
oxxa23

5,970 Posts.

1150

11/01/24

13:53

Post #: 71832379
Share

Originally posted by Hawkbar33 ↑

Hi TB, While I agree the information that was presented paints an amazing picture for the future of Imugene, the patients and ultimately the shareholders, I don't feel the presentation was at a very high level.
I am a staunch supporter of Leslie however she appeared to be nervous and definitely rushed through the presentation.
She didn't miss a beat and is clearly across her brief but the speed and tone of her presentation was little lacking.
We will see how those that attended viewed the presentation in the fullness of time, there certainly is a lot to take in for a 15 minute presentation, hopefully meetings behind the scenes provide opportunities for attendees to see a more relaxed Leslie who is able to expand on the information she presented.
The information itself paints a picture of a very strong biotechnology company, money in the bank, experienced & knowledgeable management, manufacturing capability, strong relationship with FDA and other regulatory authorities and of course amazing patent life.
All indicators, fundamental and Technical analysis point to a change in mood in the investment community for bio companies and barring events coming from left field on a macro level we should see some gains this year.
Above all else we should see medical advancement of the likes we have never seen, which hopefully will provide hope to those that are suffering from this insidious disease.
Thankyou for your views and knowledge you impart on this forum, it certainly helps to maintain confidence when things aren't looking so rosy.

DYOR opinion only

Expand

you wanted her to slow down when only 15 minutes? she wouldn't have gotten past page 5...

IMU Price at posting: 12.3¢ Sentiment: Buy Disclosure: Held
15 Upvote

0 Great analysis

Reply

Top Stories

Results wrap: Austal, TPG Telecom and Downer

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

HVN

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

EBR

EBR reaches review milestone for wireless cardiac pacing device

PYC

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

LLC

Lendlease sells off US east coast construction operations in latest global divestment push

HLX

Helix investor makes partial takeover bid, proposing board changes

TBN

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

CYM

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

VYS

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

There are more pages in this discussion • 24 more messages in this thread...

First 62 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 6.2¢		Change 0.003(5.08%)		Mkt cap ! $455.6M

Open	High	Low	Value	Volume
5.8¢	6.5¢	5.7¢	$1.751M	28.44M

Buyers (Bids)

No.	Vol.	Price($)
6	660964	6.1¢

Sellers (Offers)

Price($)	Vol.	No.
6.2¢	549788	5

View Market Depth

No.	Vol.	Price($)
6	660964	0.061
10	1109613	0.060
3	465000	0.059
8	2031160	0.058
9	1210001	0.057

Price($)	Vol.	No.
0.062	549788	5
0.063	313635	6
0.064	1129381	10
0.065	1261036	13
0.066	1433220	8

Last trade - 16.10pm 30/08/2024 (20 minute delay)

IMU (ASX) Chart

Ann: Imugene Presentation to JPMorgan Healthcare Conference, page-62

Results wrap: Austal, TPG Telecom and Downer

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

EBR reaches review milestone for wireless cardiac pacing device

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Lendlease sells off US east coast construction operations in latest global divestment push

Helix investor makes partial takeover bid, proposing board changes

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Imugene Presentation to JPMorgan Healthcare Conference, page-62

Top Stories

Results wrap: Austal, TPG Telecom and Downer

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

EBR reaches review milestone for wireless cardiac pacing device

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Lendlease sells off US east coast construction operations in latest global divestment push

Helix investor makes partial takeover bid, proposing board changes

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News